Global reporting of progress towards elimination of hepatitis B and hepatitis C
Fuqiang Cui(Peking University), Daniel Low‐Beer(World Health Organization), Peter Vickerman(At Bristol), Mónica Alonso González(Consumer Healthcare Products Association), Polin Chan(Western University), Casimir Manzengo Mingiedi(World Health Organization Regional Office for Africa), Timothy B. Hallett(Imperial College London), Olufunmiayo Lesi(World Health Organization), Philippa Easterbrook(World Health Organization), Homie Razavi(Center for Disease Analysis), Niklas Luhmann(World Health Organization - Pakistan), Sarah Blach(Center for Disease Analysis), Catherine de Martel(Centre international de recherche sur le cancer), Ahmed Sabry Alaama(World Health Organization Regional Office for the Eastern Mediterranean), Linh‐Vi Le(World Health Organization Regional Office for the Western Pacific), Antons Mozalevskis(World Health Organization), Meg Doherty(World Health Organization), Mae Dirac(Institute for Health Metrics and Evaluation), Bharat Bhushan Rewari(National AIDS Control Organisation), Nicole Seguy(World Health Organization Regional Office for Europe), Shevanthi Nayagam(Imperial College London)
Cited by 323
Related Papers
Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis
|The Lancet Global Health|2019|2.4k
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
|The Lancet. Gastroenterology & hepatology|2016|2k
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030
|Journal of Hepatology|2018|2k
Global epidemiology and genotype distribution of the hepatitis C virus infection
|Journal of Hepatology|2014|1.9k
Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections
|Nature Medicine|2002|1.6k